Search Results1-20 of  31

  • 1 / 2
  • KANKI Masayuki ID: 9000258713113

    Drug Safety Research Labs., Astellas Pharma Inc. （2013 from CiNii）

    Articles in CiNii:1

    • Identification of novel biomarkers for drug-induced renal papillary necrosis in rats by toxicoproteomics （2013）
  • KANKI Masayuki ID: 9000258713303

    Drug Safety Research Laboratories, Astellas Pharma Inc. （2013 from CiNii）

    Articles in CiNii:1

    • Relationship between regional variation of renal miRNA expression and nephrotoxicity （2013）
  • KANKI Masayuki ID: 9000258714178

    Drug Safety Research Labs, Astellas Pharma Inc. （2013 from CiNii）

    Articles in CiNii:1

    • Relationship between DNA methylation and gene expression in liver carcinogenesis （2013）
  • KANKI Masayuki ID: 9000258714196

    Drug Safety Research Laboratories, Astellas Pharma Inc. （2013 from CiNii）

    Articles in CiNii:1

    • Characterization of urinary microRNAs that could detect cisplatin-induced nephrotoxicity in rat （2013）
  • KANKI Masayuki ID: 9000283730333

    Drug Safety Research Labs., Astellas Pharma Inc. （2012 from CiNii）

    Articles in CiNii:1

    • Toxicoproteomic and toxicogenomic approaches: Identification and verification of novel biomarkers for renal papillary necrosis in rats （2012）
  • KANKI Masayuki ID: 9000283730862

    Drug Safety Research Laboratories, Astellas Pharma Inc. （2012 from CiNii）

    Articles in CiNii:1

    • MicroRNA expression analysis in cisplatin-treated rat urine （2012）
  • KANKI Masayuki ID: 9000283730872

    Drug Safety Research Laboratories, Astellas Pharma Inc. （2012 from CiNii）

    Articles in CiNii:1

    • Molecular toxicological evaluations of hepatocarcinogenesis in rat 2-stage liver carcinogenesis model -4. hepatic glycan profile analysis by using lectin array （2012）
  • KANKI Masayuki ID: 9000283730883

    Drug Safety Research Laboratories, Astellas Pharma Inc. （2012 from CiNii）

    Articles in CiNii:1

    • Molecular toxicological evaluations of hepatocarcinogenesis in rat 2-stage liver carcinogenesis model -1. application of toxicogenomics for sensitive detection of initiation activity of hepatocarcinogens （2012）
  • KANKI Masayuki ID: 9000283730888

    Drug Safety Research Labs, Astellas Phrama Inc. （2012 from CiNii）

    Articles in CiNii:1

    • Molecular toxicological evaluations of hepatocarcinogenesis in rat 2-stage liver carcinogenesis model -2. comprehensive microRNA analysis and exploring biomarkers in the liver and plasma （2012）
  • KANKI Masayuki ID: 9000283730907

    Drug Safety Research Labs, Astellas Pharma Inc. （2012 from CiNii）

    Articles in CiNii:1

    • Molecular toxicological evaluations of hepatocarcinogenesis in rat 2-stage liver carcinogenesis model -3. Comprehensive DNA methylation analysis of liver using next generation sequencer （2012）
  • KANKI Masayuki ID: 9000283732788

    Drug Safety Research Labs., Astellas Pharma Inc., Japan （2012 from CiNii）

    Articles in CiNii:1

    • Identification and verification of novel biomarkers for drug-induced renal papillary necrosis in rats using toxicoproteomic and toxicogenomic approaches （2012）
  • KANKI Masayuki ID: 9000345268078

    Drug Safety Research Labs, Astellas Pharma Inc. （2016 from CiNii）

    Articles in CiNii:1

    • Urinary microRNA biomarkers in drug-induced nephrotoxicity （2016）
  • KANKI Masayuki ID: 9000347140840

    Drug Safety Research Laboratories, Astellas Pharma Inc. （2014 from CiNii）

    Articles in CiNii:1

    • Evaluation of usability of exosomal miR-122 in rat models of drug-induced liver injury （2014）
  • KANKI Masayuki ID: 9000347141105

    Drug Safety Research Laboratories, Astellas Pharma Inc. （2014 from CiNii）

    Articles in CiNii:1

    • MicroRNA biomarkers in urine for detection of drug-induced nephrotoxicity （2014）
  • KANKI Masayuki ID: 9000391993311

    Drug Safety Research Laboratories, Drug Discovery Research Division, Astellas Pharma Inc. （2009 from CiNii）

    Articles in CiNii:1

    • Prediction model construction and marker genes extraction for cholestasis using toxicogenoimcs approach in rats （2009）
  • KANKI Masayuki ID: 9000391995037

    Drug Safety Research Laboratories, Astellas Pharma Inc. （2010 from CiNii）

    Articles in CiNii:1

    • Novel biomarkers of glutathione depletion associated hepatotoxicity by using cross-omics technology （2010）
  • KANKI Masayuki ID: 9000391997954

    Drug Safety Research Laboratories, Astellas Pharma Inc. （2010 from CiNii）

    Articles in CiNii:1

    • Computational approach for assessment of glutathione depletion based on gene expression data （2010）
  • KANKI Masayuki ID: 9000391998032

    Drug Safety Research Labs., Astellas Pharma Inc. （2010 from CiNii）

    Articles in CiNii:1

    • Construction of a toxicogenomic prediction model for the hepatocyte necrosis in rats （2010）
  • KANKI Masayuki ID: 9000391998135

    Drug Safety Research Laboratories, Astellas Pharma Inc. （2010 from CiNii）

    Articles in CiNii:1

    • Toxicogenomic approach for identifying marker genes of liver toxicity in rat whole blood （2010）
  • KANKI Masayuki ID: 9000391998629

    Molecular Toxiclogy, Drug safety research Labs., Astellas Pharma Inc. （2010 from CiNii）

    Articles in CiNii:1

    • Gene expression profile in rat ovarian follicle during ovulation （2010）
  • 1 / 2
Page Top